How does partial antigen matching affect alloimmunization risk in chronically transfused patients?

• A. It has no effect
• B. It increases risk of alloimmunization
• C. Matching for additional antigens (e.g., Kell, Duffy, Kidd) lowers alloantibody formation and transfusion complications
• D. It only matters for pediatric patients

Answer: (C)

When someone needs frequent transfusions, their immune system keeps meeting donor red cells that may carry different antigens than their own. That exposure can trigger formation of alloantibodies against those non-self antigens, which makes future transfusions harder and increases the risk of reactions.

Extending antigen matching beyond ABO and Rh(D) to include clinically significant antigens like Kell, Duffy, and Kidd reduces this immune stimulation. By providing units that are matched for these additional antigens, the patient is less likely to develop antibodies against them. Fewer alloantibodies translate into fewer transfusion complications, fewer delays while searching for compatible blood, and a lower risk of hemolytic reactions.

This approach is especially important for chronically transfused patients because of their repeated exposure to donor cells; the benefit is not limited to children. While perfect matching for every possible antigen isn’t always practical, targeting these common, highly immunogenic antigens appreciably lowers alloimmunization risk.